Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 102

Sort by

Sort Order Select

Journal Articles

Indolent lymphomas: pushing the pace with novel agents

Caron A. Jacobson

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 279–286.

https://doi.org/10.1182/hematology.2019000032

Published: 2019

Journal Articles

Myeloma: next generation immunotherapy

Adam D. Cohen

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 266–272.

https://doi.org/10.1182/hematology.2019000068

Published: 2019

Journal Articles

Update from the laboratory: mechanistic studies of pathways of cancer-associated venous thrombosis using mouse models

Yohei Hisada, Nigel Mackman

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 182–186.

https://doi.org/10.1182/hematology.2019000025

Published: 2019

Journal Articles

Clonal dynamics in chronic lymphocytic leukemia

Catherine Gutierrez, Catherine J. Wu

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 466–475.

https://doi.org/10.1182/hematology.2019000367

Published: 2019

Journal Articles

Cause-specific late mortality after allogeneic stem cell transplantation

Smita Bhatia

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 626–629.

https://doi.org/10.1182/hematology.2019000004

Published: 2019

Journal Articles

Integrating patient-centered factors in the risk assessment of MDS

Rena J. Buckstein

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 373–380.

https://doi.org/10.1182/hematology.2019000041

Published: 2019

Journal Articles

Genomics of aggressive B-cell lymphoma

Allison Rosenthal, Lisa Rimsza

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 69–74.

https://doi.org/10.1182/asheducation-2018.1.69

Published: 2018

Journal Articles

Treatments targeting MDS genetics: a fool’s errand?

Amy E. DeZern

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 277–285.

https://doi.org/10.1182/asheducation-2018.1.277

Published: 2018

Journal Articles

Where to start? Upfront therapy for follicular lymphoma in 2018

John P. Leonard, Loretta J. Nastoupil, Christopher R. Flowers

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 185–188.

https://doi.org/10.1182/asheducation-2018.1.185

Published: 2018

Journal Articles

Clinical consequences of clonal hematopoiesis of indeterminate potential

David P. Steensma

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 264–269.

https://doi.org/10.1182/asheducation-2018.1.264

Published: 2018

Journal Articles

Role of the microenvironment across histological subtypes of NHL

Karin Tarte

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 610–617.

https://doi.org/10.1182/asheducation-2017.1.610

Published: 2017

Journal Articles

Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents

Andrés José María Ferreri

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 565–577.

https://doi.org/10.1182/asheducation-2017.1.565

Published: 2017

Journal Articles

Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma

W. Robert Liu, Margaret A. Shipp

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 310–316.

https://doi.org/10.1182/asheducation-2017.1.310

Published: 2017

Journal Articles

Follicular lymphoma: are we ready for a risk-adapted approach?

Brad S. Kahl

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 358–364.

https://doi.org/10.1182/asheducation-2017.1.358

Published: 2017

Journal Articles

Acquired ribosomopathies in leukemia and solid tumors

Adrianna Vlachos

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 716–719.

https://doi.org/10.1182/asheducation-2017.1.716

Published: 2017

Journal Articles

Graft versus tumor effects and why people relapse

J. H. Frederik Falkenburg, Inge Jedema

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 693–698.

https://doi.org/10.1182/asheducation-2017.1.693

Published: 2017

Journal Articles

Therapy-related myeloid neoplasms: does knowing the origin help to guide treatment?

Michael Heuser

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 24–32.

https://doi.org/10.1182/asheducation-2016.1.24

Published: 2016

Journal Articles

Novel agents in follicular lymphoma: choosing the best target

Laurie H. Sehn

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 284–292.

https://doi.org/10.1182/asheducation-2016.1.284

Published: 2016

Journal Articles

Minimal residual disease in mantle cell lymphoma: insights into biology and impact on treatment

Eva Hoster, Christiane Pott

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 437–445.

https://doi.org/10.1182/asheducation-2016.1.437

Published: 2016

Journal Articles

New challenges in evaluating anemia in older persons in the era of molecular testing

David P. Steensma

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 67–73.

https://doi.org/10.1182/asheducation-2016.1.67

Published: 2016

NARROW

Indolent lymphomas: pushing the pace with novel agents

Myeloma: next generation immunotherapy

Update from the laboratory: mechanistic studies of pathways of cancer-associated venous thrombosis using mouse models

Clonal dynamics in chronic lymphocytic leukemia

Cause-specific late mortality after allogeneic stem cell transplantation

Integrating patient-centered factors in the risk assessment of MDS

Genomics of aggressive B-cell lymphoma

Treatments targeting MDS genetics: a fool’s errand?

Where to start? Upfront therapy for follicular lymphoma in 2018

Clinical consequences of clonal hematopoiesis of indeterminate potential

Role of the microenvironment across histological subtypes of NHL

Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents

Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma

Follicular lymphoma: are we ready for a risk-adapted approach?

Acquired ribosomopathies in leukemia and solid tumors

Graft versus tumor effects and why people relapse

Therapy-related myeloid neoplasms: does knowing the origin help to guide treatment?

Novel agents in follicular lymphoma: choosing the best target

Minimal residual disease in mantle cell lymphoma: insights into biology and impact on treatment

New challenges in evaluating anemia in older persons in the era of molecular testing

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only